MSH6 and neoplasm: Similarly, in this report, we presented a case of EC whose tumor was ultra-mutated and dMMR with MSH6 loss may be driven by the somatic POLE T278K mutation and the secondary somatic MSH6 mutations (E1234* and E1322*).